Nervous System Disorder Clinical Trial
Official title:
A Feasibility Study of the Use of Betashot, a Medium Chain Triglyceride- Based (MCT) Food for Special Medical Purposes (FSMP) in Children and Adults With Epilepsy.
In brief, this research is a prospective, feasibility study to evaluate the use of Betashot- a medium chain triglyceride- based (MCT) food for special medical purposes (FSMP) in children and adults diagnosed with epilepsy. MCT is a type of dietary fat used in the ketogenic diet.
This study aims to explore the use of Betashot in a group of children and adults with epilepsy who are consuming their normal diets, but limiting intakes of foods high in carbohydrate and sugars. The participants will be required to drink Betashot to enable the following assessment: 1. Tolerance (side effects such as bloating or cramps) 2. Acceptability (flavour, texture, taste) 3. Compliance (how easy it is to use Betashot at the advised quantity, as part of their daily diet) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01425983 -
Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
|
Phase 3 | |
| Recruiting |
NCT05518617 -
Molecular and Functional Imaging in Monogenic PD.
|
||
| Completed |
NCT01255358 -
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
|
Phase 2 |